Patents Assigned to Adenium Biotech A/S
  • Publication number: 20160158317
    Abstract: The present invention relates to variants of a parent antimicrobial peptide. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: February 13, 2016
    Publication date: June 9, 2016
    Applicant: Adenium Biotech A/S
    Inventors: Hans-Henrik Kristensen Hoegenhaug, Per Holse Mygind, Thomas Kruse, Dorotea Raventos Segura, Dorthe Hoj Sandvang, Soren Neve
  • Publication number: 20120309686
    Abstract: The present invention relates to treatment of rheumatoid arthritis with mammal beta defensins.
    Type: Application
    Filed: July 9, 2012
    Publication date: December 6, 2012
    Applicant: Novozymes Adenium Biotech A/S
    Inventors: Tanja Maria Rosenkilde Kjaer, Thomas Kruse, Per Holse Mygind, Karoline Sidelmann Brinch, Soeren Kjaerulff, Birgitte Andersen
  • Publication number: 20120309678
    Abstract: The present invention relates to treatment of inflammatory bowel diseases with mammal beta defensins.
    Type: Application
    Filed: July 9, 2012
    Publication date: December 6, 2012
    Applicant: Novozymes Adenium Biotech A/S
    Inventors: Tanja Maria Rosenkilde Kjaer, Thomas Kruse, Per Holse Mygind, Karoline Sidelmann Brinch, Soeren Kjaerulff, Birgitte Andersen
  • Patent number: 8232242
    Abstract: The present invention relates to treatment of inflammatory bowel diseases with mammal beta defensins.
    Type: Grant
    Filed: July 17, 2009
    Date of Patent: July 31, 2012
    Assignee: Novozymes Adenium Biotech A/S
    Inventors: Tanja Maria Rosenkilde Kjaer, Thomas Kruse, Per Holse Mygind, Karoline Sidelmann Brinch, Soeren Kjaerulff, Birgitte Andersen
  • Patent number: 8232248
    Abstract: The present invention relates to treatment of rheumatoid arthritis with mammal beta defensins.
    Type: Grant
    Filed: July 17, 2009
    Date of Patent: July 31, 2012
    Assignee: Novozymes Adenium Biotech A/S
    Inventors: Tanja Maria Rosenkilde Kjaer, Thomas Kruse, Per Holse Mygind, Karoline Sidelmann Brinch, Soeren Kjaerulff, Birgitte Andersen
  • Patent number: 8192925
    Abstract: The present invention relates to isolated polypeptides having antimicrobial activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: May 13, 2008
    Date of Patent: June 5, 2012
    Assignee: Novozymes Adenium Biotech A/S
    Inventors: Per Holse Mygind, Mogens Trier Hansen, Marianne Vind Sorensen, Dorthe Sandvang
  • Patent number: 8080390
    Abstract: The present invention relates to polypeptides having antimicrobial activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: January 19, 2009
    Date of Patent: December 20, 2011
    Assignee: Novozymes Adenium Biotech A/S
    Inventors: Hans-Henrik Kristensen Hogenhaug, Per Holse Mygind, Dorotea Raventos Segura, Olivier Taboureau, Carsten Peter Sonksen
  • Publication number: 20110160122
    Abstract: The present invention relates to isolated polypeptides having antimicrobial activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: January 5, 2011
    Publication date: June 30, 2011
    Applicant: Novozymes Adenium Biotech A/S
    Inventors: Dorotea Raventos Segura, Per Holse Mygind, Mogens Trier Hansen, Marianne Vind Soerensen, Dorthe Sandvang
  • Publication number: 20110053836
    Abstract: The present invention relates to a method for killing or inhibiting cells of Mycobacterium, in particular M. tuberculosis, with certain defensins.
    Type: Application
    Filed: November 2, 2010
    Publication date: March 3, 2011
    Applicant: NOVOZYMES ADENIUM BIOTECH A/S
    Inventors: HANS-HENRIK KRISTENSEN HOGENHAUG, GARY K. SCHOOLNIK, SIDHARTH CHOPRA, DOROTEA RAVENTOS SEGURA
  • Patent number: 7829524
    Abstract: The present invention relates to polypeptides having antimicrobial activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: June 10, 2004
    Date of Patent: November 9, 2010
    Assignee: Novozymes Adenium Biotech A/S
    Inventors: Dorotea Raventos Segura, Per Holse Mygind, Hans-Henrik Kristensen Hoegenhaug, Alessandro Tossi
  • Patent number: 7745576
    Abstract: The present invention relates to isolated polypeptides having antimicrobial activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: August 25, 2006
    Date of Patent: June 29, 2010
    Assignee: Novozymes Adenium Biotech A/S
    Inventor: Nikolaj Spodsberg
  • Publication number: 20100120690
    Abstract: The present invention relates to isolated polypeptides having antimicrobial activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: January 14, 2010
    Publication date: May 13, 2010
    Applicant: Novozymes Adenium Biotech A/S
    Inventors: Jesper Vind, Dorotea Raventos Segura, Hans-Henrik Kristensen Hoegenhaug, Per Hose Mygind, Olivier Taboureau
  • Patent number: 7671175
    Abstract: The present invention relates to isolated polypeptides having antimicrobial activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: June 5, 2006
    Date of Patent: March 2, 2010
    Assignee: Novozymes Adenium Biotech A/S
    Inventors: Jesper Vind, Dorotea Raventos Segura, Hans-Henrik Kristensen Hoegenhaug, Per Holse Mygind, Olivier Taboureau